Midori Isobe

Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Koji Kurose, Yoshihiro Ohue, Hisashi Wada et al. · Clinical Cancer Research · 2015 · 249 citations

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.

Akiko Uenaka, Hisashi Wada, Midori Isobe et al. · PubMed · 2007 · 129 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +21

A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen

Kazuhiro Kakimi, Midori Isobe, Akiko Uenaka et al. · International Journal of Cancer · 2011 · 80 citations

Esophageal Cancer, Immunodeficiencies, Immunology +24

Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients

Ryohei Kawabata, Hisashi Wada, Midori Isobe et al. · International Journal of Cancer · 2007 · 75 citations · Full text

Vaccination, Cancer Immunosurveillance, Vaccine Development +15

Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)

Koji Kurose, Yoshihiro Ohue, Eiichi Sato et al. · Journal of Thoracic Oncology · 2014 · 53 citations · Full text

Cancer Immunosurveillance, Oncogenic Agent, Immunology +9